- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2026
- 280 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 377 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 485 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 371 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 469 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 172 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 274 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 476 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 278 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 461 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 483 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 280 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 383 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 378 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 467 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 480 Pages
Global
From €5102EUR$5,850USD£4,425GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more